Table 1.

Demographic and Clinical Characteristics (n = 2000)

Characteristic	n	%
Age (years) mean = 46.0 (±11.7)
18–24	32	1.6
25–34	385	19.3
35–44	432	21.6
45–54	637	31.9
55–64	422	21.1
65–83	92	4.6
Birth sex
Male	1637	86.8
Female	249	13.2
Gender
Man	1294	82.9
Woman	239	15.3
Transgender	28	1.8
Race
Caucasian	1330	68.0
African American	478	24.4
American Indian	30	1.5
Asian Pacific Islander	64	3.3
Other/Unknown	54	2.8
Ethnicity
Hispanic	366	20.3
Non-Hispanic	1437	79.7
Risk factors
Heterosexual	381	19.3
Men who have sex with men	1314	66.5
Intravenous drug use	93	4.7
Men who have sex with men and intravenous drug use	130	6.6
Other	57	2.9
Unknown	25	1.3
Insurance
Private	469	23.5
Public	830	41.5
Uninsured	281	14.1
Ryan-White	128	6.4
Site
Case Western Reserve University	166	8.3
Fenway	272	13.6
University of Alabama at Birmingham	116	5.8
University of California, San Diego	731	36.6
University of North Carolina	248	12.4
University of Washington	467	23.4
Antiretroviral therapy naïve (% yes)	912	45.6
Antiretroviral therapy class
Integrase-inhibitor based regimen	1453	76.0
Non-nucleoside reverse transcriptase inhibitors	268	14.0
Other	191	10.0
CD4 Count in cells/mm3 n = 1481
Mean = 628 (±333)
≤200	126	8.5
201–500	422	28.5
>500	933	63.0
Viral Load in copies/mL n = 607
Range [19–502,700]
<50	523	86.2
51 to ≤200	21	3.5
201 to ≤499	8	1.3
500 to ≤10,000	19	3.1
>10,000	36	5.9
Hepatitis C (% yes)	273	13.7

Abbreviations: mm³ = millimeter cubed; mL = milliliter.